Completed Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas NCT00453427 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more Locations St. Paul's Hospital — Vancouver, British Columbia, Canada Juravinski Cancer Centre — Hamilton, Ontario, Canada London Health Sciences Centre — London, Ontario, Canada Sunnybrook Health Sciences Centre, Odette Cancer Centre — Toronto, Ontario, Canada View more locations Show fewer locations Loading locations... View Trial Details
Completed Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas NCT00374699 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more Locations Samsung Medical Center — Seoul, South Korea View Trial Details
Active, Not Recruiting Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma NCT03922724 Conditions Autoimmune Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States National Marrow Donor Program — Minneapolis, Minnesota, United States View Trial Details
